ACV Auctions (ACVA) Competitors

ACV Auctions (NASDAQ:ACVA) and Medpace (NASDAQ:MEDP) are both mid-cap retail/wholesale companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings.

Do institutionals & insiders have more ownership in ACVA or MEDP?

88.6% of ACV Auctions shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 8.5% of ACV Auctions shares are owned by company insiders. Comparatively, 20.3% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the media prefer ACVA or MEDP?

In the previous week, Medpace had 18 more articles in the media than ACV Auctions. MarketBeat recorded 29 mentions for Medpace and 11 mentions for ACV Auctions. ACV Auctions' average media sentiment score of 1.58 beat Medpace's score of 0.74 indicating that ACV Auctions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ACV Auctions	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Medpace	20 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings and valuation, ACVA or MEDP?

Medpace has higher revenue and earnings than ACV Auctions. ACV Auctions is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ACV Auctions	$637.16M	4.04	-$79.70M	-$0.49	-31.10
Medpace	$2.16B	4.07	$404.39M	$13.10	23.29

Which has more volatility & risk, ACVA or MEDP?

ACV Auctions has a beta of 1.74, meaning that its share price is 74% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500.

Do analysts prefer ACVA or MEDP?

ACV Auctions presently has a consensus price target of $22.50, suggesting a potential upside of 47.64%. Medpace has a consensus price target of $349.30, suggesting a potential upside of 14.48%. Given ACV Auctions' stronger consensus rating and higher possible upside, equities research analysts plainly believe ACV Auctions is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ACV Auctions	0 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.82
Medpace	0 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.23

Is ACVA or MEDP more profitable?

Medpace has a net margin of 19.17% compared to ACV Auctions' net margin of -12.51%. Medpace's return on equity of 51.48% beat ACV Auctions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ACV Auctions	-12.51%	-12.94%	-5.75%
Medpace	19.17%	51.48%	20.47%

Does the MarketBeat Community prefer ACVA or MEDP?

Medpace received 280 more outperform votes than ACV Auctions when rated by MarketBeat users. Likewise, 62.81% of users gave Medpace an outperform vote while only 57.48% of users gave ACV Auctions an outperform vote.

Company	Underperform	Outperform
ACV Auctions	Outperform Votes 73 57.48%	Underperform Votes 54 42.52%
Medpace	Outperform Votes 353 62.81%	Underperform Votes 209 37.19%

Summary

Medpace beats ACV Auctions on 12 of the 18 factors compared between the two stocks.